Diagnostic Molecular Cytopathology - a further decade of progress

Cytopathology

Volumn 26, Issue 5, 2015, Pages 269-270

  Salto Tellez, M ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; K RAS PROTEIN;

CLONAL VARIATION; COLORECTAL CANCER; CYTOPATHOLOGY; EDITORIAL; ENDOBRONCHIAL ULTRASONOGRAPHY; FINE NEEDLE ASPIRATION BIOPSY; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; GLIOMA; HUMAN; HYBRIDIZATION; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MELANOMA; MICROSATELLITE INSTABILITY; MOLECULAR DIAGNOSIS; MOLECULAR DIAGNOSTICS; PRIORITY JOURNAL; SARCOMA; SOLID TUMOR; MOLECULAR PATHOLOGY; PROCEDURES;

HUMANS; PATHOLOGY, MOLECULAR;

EID: 84942123868     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/cyt.12276     Document Type: Editorial

References (22)

1. Salto-Tellez M, Koay ES. Molecular diagnostic cytopathology: definitions, scope and clinical utility. Cytopathology 2004;15:252-5.
2. Lee V, Ng S-B, Salto-Tellez M. Section 16 New Techniques, Chapter 34 "New techniques". In: Diagnostic Cytopathology, 3rd edn. Gray W, Kocjan G (eds). Edinburgh: Churchill Livingstone/Elsevier; 2010: pp. 891-902.
3. Salto-Tellez M. A case for integrated morphomolecular diagnostic pathologists. Clin Chem 2007;53:1188-90.
4. Lynch TJ, Bell DW, Sordella R et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004;350:2129-39.
5. Paez JG, Jänne PA, Lee JC et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004;304:1497-500.
6. Lièvre A, Bachet JB, Le Corre D et al. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res 2006;66:3992-5.
7. Chapman PB, Hauschild A, Robert C et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011;364:2507-16.
8. Pang NK, Nga ME, Chin SY et al. KRAS and BRAF mutation analysis can be reliably performed on aspirated cytological specimens of metastatic colorectal carcinoma. Cytopathology 2011;22:358-64.
9. Pang B, Dettmer M, Ong CW et al. The positive impact of cytological specimens for EGFR mutation testing in non-small cell lung cancer: a single South East Asian laboratory's analysis of 670 cases. Cytopathology 2012;23:229-36.
10. Neat MJ, Foot NJ, Hicks A et al. ALK rearrangements in EBUS-derived transbronchial needle aspiration cytology in lung cancer. Cytopathology 2013;24:356-64.
11. Bernacki KD, Betz BL, Weigelin HC et al. Molecular diagnostics of melanoma fine-needle aspirates: a cytology-histology correlation study. Am J Clin Pathol 2012;138:670-7.
12. Jurado J, Saqi A, Maxfield R et al. The efficacy of EBUS-guided transbronchial needle aspiration for molecular testing in lung adenocarcinoma. Ann Thorac Surg 2013;96:1196-202.
13. Barr Fritcher EG, Kipp BR, Halling KC, Clayton AC. FISHing for pancreatobiliary tract malignancy in endoscopic brushings enhances the sensitivity of routine cytology. Cytopathology 2014;25:288-301.
14. Bongiovanni M, Molinari F, Eszlinger M, et al. Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience. Cytopathology 2015;26:288-96.
15. Capelli L, Marfisi C, Puccetti M, et al. Role of BRAF molecular analysis in the management of papillary thyroid carcinoma: analysis of cytological and histological samples. Cytopathology 2015;26:297-302.
16. Addati T, Achille G, Centrone M, et al. TROP-2 expression in papillary thyroid cancer: a preliminary cyto-histological study. Cytopathology 2015;26:303-11.
17. Pagni F, Mainini V, Garancini M, et al. Proteomics for the diagnosis of thyroid lesions: preliminary report. Cytopathology 2015;26:318-24.
18. McCourt CM, Boyle D, James J, Salto-Tellez M. Immunohistochemistry in the era of personalised medicine. J Clin Pathol 2013;66:58-61.
19. Cheng DT, Mitchell TN, Zehir A et al. Memorial Sloan Kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J Mol Diagn 2015;17:251-64.
20. Frampton GM, Fichtenholtz A, Otto GA et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol 2013;31:1023-31.
21. Vigliar E, Malapelle U, de Luca C, Bellevicine C, Troncone G. Challenges and opportunities of next-generation sequencing: a cytopathologist's perspective. Cytopathology 2015;26:271-83.
22. Catherwood MA, Schmitt F, Salto-Tellez M. Molecular diagnostics and the training of future tissue- and cell-based pathologists. Cytopathology 2012;23:283-5.